| Start: | Jun 14, 2023 - 4:00 pm |
| End: | Jun 14, 2023 - 6:00 pm |
| Venue: | Online event |
| Event website: | https://forms.gle/sVbeaNv1VsWiV5Ur7 |
Dear ETPN colleagues, we are pleased to invite you to participate in the upcoming Webinar “Road to market: The path of RUBYnanomed“ to be held on June 14th at 15:00 WEST organised by RUBYnanomed, a spin-off from our long-term partner and ETPN member institution : INL. RUBYnanomed has received long-term surpport from our industry mentoring the HealthTech TAB.
RUBYnanomed is bringing to the market a non-invasive in vitro diagnostics tool for cancer patient monitoring based on liquid biopsy. During this one-hour interactive webinar, we will present the main benefits of the technology to share insights about bringing a medical device to market. Attendees can expect a first-hand experience in scaling-up a novel microfluidic technology, focusing on product development, industrialisation and regulatory roadmap. The session includes the vision from the clinicians and regulatory experts.
Agenda:
- 14:00 – 14:05 Welcome
- 14:05 – 14:20 The BRIGHT project – Dr Lorena Diéguez, co-founder and CEO of RUBYnanomed
- 14:20 – 14:30 Industrialising and IVD – Juan F Roman – VP Strategic Development, Veranex
- 14:30 – 14:40 Regulatory challenges – Miguel Amador, Chief Innovation Officer, Complear
- 14:40 – 14:50 Clinical Impact – Dr Laura Muinelo, Responsible of Liquid Biopsy Unit, Oncomet
- 14:50 – 15:00 Questions & Answers
This webinar is organised in the framework of the BRIGHT project, funded by the European Regional Development Fund (ERDF) of the European Union, through the Programa Operacional Regional do Norte (NORTE 2020) of the Portugal 2020. The objective of this project is to mature our technology for the analysis of CTCs in cancer patients.
We are really looking forward to sharing with you the results of our project.
Register for free
To attend the event, please register for free here.